cagrilintide 5mg+Samaglutide5mg MZ SUR10 CS5 cagrilintide 5mg+Samaglutide5mg BPC10mg,TB10mg,GHK-CU50
TDS 30 Inquiries
12656-61-0
Pharmaceutical Grade
99%
shenzhen
sc
5 mg / 10 mg / 20 mg. 10 bottles per box
Yes
2027-03-04
tr
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
Cerebrolysin
Other Name:Cerebrolysin;FPE 1070
CAS No.:12656-61-0
EC Number:1592732-453-0
Categories:
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
tr
-
Location:
B27 SHING LEE COMM BLDG 8WING KUT ST CENTRAL HONGKONG
-
Average lead Time:
1 days
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
-
Inquiry History30 Inquiries
Country Product Purchase Quantity Date Posted
United States
CEREBROLYSIN
1 MT Mar 10, 2026
United States
Cerebrolysin
60 MG Jun 26, 2026
United States
cerebrolysin
5 PCS May 26, 2026
United States
Cerebrolysin
10 G Apr 7, 2026
United States
Cerebrolysin
25 G Mar 23, 2026
United States
CEREBROLYSIN
2 Feb 26, 2026
United States
Cerebrolysin
60 MG Feb 26, 2026
United States
cerebrolysin
1 KG Jan 20, 2026
Lithuania
High Quality Cerebrolysin
1000 MG Jan 30, 2025
Egypt
Cerebrolysin
1 G Dec 25, 2024
South Korea
cerebrolysin
500 G Mar 28, 2024
United States
Cerebrolysin
3 PCS Oct 1, 2026
Lithuania
Cerebrolysin
10 G Sep 14, 2026
United States
Cerebrolysin
10 G Jul 8, 2026
United States
Cerebrolysin
5 G Jun 29, 2026
Ireland
cerebrolysin
1 L Jun 26, 2026
United States
cerebrolysin
3 PCS May 13, 2026
South Africa
Cerebrolysin
1 KG Dec 29, 2025
United States
Cerebrolysin POWDER
1 G Dec 2, 2025
United Kingdom
Cerebrolysin Raw Powder
10 G Nov 3, 2025 Post an enquiry for this product
More from this Seller
-
-
-
China factory peptides AOD PNC27 NJ100 BC5 GT1500 BC10 CU100
Cosmetics Grade / 99%
$1/G FOB
-
-
-
-
B12 TR10 SM20 322 LC120 HA5 TR40 AK100 RT60 TB Thymosin Acetate KS5 CGL10 BB10
Pharmaceutical Grade / 99%
$1/G FOB
-
-
-
-
Semaglutide Tirzepatide SM2 SM5 SM10 SM15 SM20 SM30 TR5 TR10 TR15 TR20 TR30 TR40 TR50 TR60 price moderate
Pharmaceutical Grade / 99%
$1/G FOB
-
